BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 21312259)

  • 1. The post-platelet 100,000 count: effects of platelet collection and future.
    Jaben EA; Gandhi MJ
    J Clin Apher; 2011; 26(1):53-5. PubMed ID: 21312259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postdonation platelet counts are safe when collecting platelets with the Trima Accel using a postdonation platelet count target of > or =50,000 platelets/microL.
    Alex J; Roberts B; Raife T
    J Clin Apher; 2009; 24(5):215-7. PubMed ID: 19816960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequent plateletpheresis does not clinically significantly decrease platelet counts in donors.
    Katz L; Palmer K; McDonnell E; Kabat A
    Transfusion; 2007 Sep; 47(9):1601-6. PubMed ID: 17725723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the performance of Trima Accel® v5.2 for the collection of concentrated high-dose platelet products and concurrent plasma from high platelet count donors, in Germany.
    Daskalakis M; Schulz-Huotari C; Burger M; Klink I; Umhau M
    J Clin Apher; 2012; 27(2):75-80. PubMed ID: 22362609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of donor factors contributing to plateletpheresis yields among apheresis platelet donors.
    Woodall WJ; Nguyen VQ; Tran MH
    J Clin Apher; 2014 Jun; 29(3):139-47. PubMed ID: 24222645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A statistical model for estimating donor postdonation platelet counts after plateletpheresis.
    Cabezudo I; Winegarden DK; Randels MJ; Strauss RG
    Transfusion; 1994 Jan; 34(1):54-7. PubMed ID: 8273130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paired crossover study of two plateletpheresis systems concerning platelet product quality and donor comfort.
    Flesch BK; Adamzik I; Steppat D; Miller J; Carstensen L; Schapke M; Davey J
    Transfusion; 2010 Apr; 50(4):894-901. PubMed ID: 19951314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality and safety of platelet apheresis concentrates produced with a new leukocyte reduction system.
    Riggert J; Humpe A; Simson G; Köhler M
    Vox Sang; 1998; 74(3):182-8. PubMed ID: 9595646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequently used plateletpheresis techniques result in variable target yields and platelet recruitment of donors.
    Strasser EF; Schuster M; Egler K; Bauer J; Weisbach V; Ringwald J; Zimmermann R; Zingsem J; Eckstein R
    Transfusion; 2005 May; 45(5):788-97. PubMed ID: 15847670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of PEG-rhuMGDF in platelet apheresis.
    Kuter DJ
    Stem Cells; 1998; 16 Suppl 2():231-42. PubMed ID: 11012195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A critical comparison of platelet preparation methods.
    Vassallo RR; Murphy S
    Curr Opin Hematol; 2006 Sep; 13(5):323-30. PubMed ID: 16888436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of Fenwal Amicus blood cell separator in double dose platelet collection.
    Gürak S; Arslan O
    Transfus Apher Sci; 2007 Feb; 36(1):69-72. PubMed ID: 17270496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The influence of initial values of donor platelets count on the efficiency of plateletpheresis with the cell separator Fenval Baxter Amicus s.v.2.51].
    Landzo E; Berbić-Fazlagić J; Sofo-Hafizović A
    Med Arh; 2009; 63(2):67-70. PubMed ID: 19537658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pre-apheresis donor platelet count: an important platelet yield predictor.
    Saluja K; Thakral B; Sharma RR; Marwaha N
    J Clin Apher; 2006 Dec; 21(4):274. PubMed ID: 16847940
    [No Abstract]   [Full Text] [Related]  

  • 15. A 3-year analysis of plateletpheresis donor deferral pattern in a tertiary health care institute: assessing the current donor selection criteria in Indian scenario.
    Tondon R; Pandey P; Chaudhry R
    J Clin Apher; 2008; 23(4):123-8. PubMed ID: 18615635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Collection of hyperconcentrated platelets with Trima Accel.
    Ringwald J; Duerler T; Frankow O; Zimmermann R; Zingsem J; Strasser E; Antoon M; Eckstein R
    Vox Sang; 2006 Feb; 90(2):92-6. PubMed ID: 16430666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Plateletpheresis with the new cell separator A 201 (Baxter)].
    Luboldt W; Moog R
    Beitr Infusionsther; 1991; 28():195-200. PubMed ID: 1725618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemoglobin and platelet count effect on platelet yields in plateletpheresis.
    Guerrero-Rivera S; Gutiérrez-Espíndola G; Talavera JO; Meillón-García LA; Pedraza-Echevarría M; Pizzuto-Chávez J
    Arch Med Res; 2003; 34(2):120-3. PubMed ID: 12700007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective, paired crossover comparison of multiple, single-needle plateletpheresis procedures with the Amicus and Trima Accel cell separators.
    Fontana S; Mordasini L; Keller P; Taleghani BM
    Transfusion; 2006 Nov; 46(11):2004-10. PubMed ID: 17076857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of platelet parameters in healthy apheresis donors using the ADVIA 120.
    Ifran A; Haşimi A; Kaptan K; Nevruz O; Beyan C; Erbil K
    Transfus Apher Sci; 2005 Oct; 33(2):87-90. PubMed ID: 16139569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.